Condition: Pancreas Cancer · Colon Cancer · Biliary Tract Cancer · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract.
This description comes directly from the study's public registry record.
Lisa Salvatore, MD, PhD · +390630156318 · lisa.salvatore@policlinicogemelli.it
Giovanni Trovato, MD · +390630156318 · giovanni.trovato@guest.policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Policlinico Agostino Gemelli | Rome, Lazio, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06202131